(Q52298270)

English

Commentary on Halpern et al. (2011): strengthening the case against functionally significant serotonergic neurotoxicity in human MDMA (ecstasy) users.

scientific article published in April 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/21371152

0 references

Commentary on Halpern et al. (2011): strengthening the case against functionally significant serotonergic neurotoxicity in human MDMA (ecstasy) users. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/21371152

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/21371152

language of work or name

0 references

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/21371152

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/21371152

106

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/21371152

4

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/21371152

787-788

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/21371152

Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Have Halpern et al. (2004) detected 'residual neuropsychological effects' of MDMA? Not likely

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Reduced frontal lobe activity in subjects with high impulsivity and alcoholism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Decision making as a predictor of first ecstasy use: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Quantitative positron emission tomography studies of the serotonin transporter in humans previously treated with the appetite suppressants fenfluramine or dexfenfluramine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Risky alcohol use and age at onset of regular alcohol consumption in relation to frontal lobe indices, reward sensitivity, and rash impulsiveness

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Assessment of strategic self-regulation in traumatic brain injury: its relationship to injury severity and psychosocial outcome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03344.X

21 January 2018

Identifiers

10.1111/J.1360-0443.2010.03344.X

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/21371152

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/21371152

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52298270&oldid=2125656021"